top of page
News
April 2021
Lichtsteiner Foundation Testimonial Film about Synendos
March 2021
Scientific publication about the beneficial effect of the prototype SERI WOBE437 in a clinically relevant mouse model of Multiple Sclerosis and transient spasticity
November 2020
Synendos Therapeutics Raises CHF 20 Million in Series A Financing
October 2020
Synendos and Prof. Jürg Gertsch received an Innosuisse Innovation Grant (total value of CHF 950’000)
November 2019
Award ceremony Venture Leaders 2019
bottom of page